CSIMarket
 


Akers Biosciences Inc   (AKER)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AKER's Net Income Growth by Quarter and Year

Akers Biosciences Inc 's Net Income results by quarter and year




AKER Net Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -1.34 -3.84 -4.17
III Quarter September -7.13 -0.84 -3.08 -1.18
II Quarter June -3.63 -0.79 -2.07 -0.82
I Quarter March -3.54 -0.92 -1.86 -1.35
FY   -14.30 -3.89 -10.85 -7.52



AKER Net Income third quarter 2020 Y/Y Growth Comment
Akers Biosciences Inc in the third quarter recorded net loss of $ -7.13 millions.

According to the results reported in the third quarter, Akers Biosciences Inc achieved the best Net Income growth in Biotechnology & Drugs industry. While Akers Biosciences Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter.




AKER Net Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Akers Biosciences Inc 's third quarter 2020 Net Income $ -7.13 millions AKER's Income Statement
Akers Biosciences Inc 's third quarter 2019 Net Income $ -0.84 millions Quarterly AKER's Income Statement
New: More AKER's historic Net Income Growth >>


AKER Net Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Akers Biosciences Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AKER's III. Quarter Q/Q Net Income Comment
Recent net loss of -7.13 millions by Akers Biosciences Inc come out even more unfavourable compare to the net loss -3.63 millions in the previous quarter.

Within Biotechnology & Drugs industry Akers Biosciences Inc achieved highest sequential Net Income growth. While Akers Biosciences Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AKER's III. Quarter Q/Q Net Income Comment
Recent accomplishment of -7.13 millions by Akers Biosciences Inc look even worse if you take a look at -3.63 millions in the second quarter.

Within Biotechnology & Drugs industry Akers Biosciences Inc achieved highest sequential Net Income growth. While Akers Biosciences Inc 's Net Income growth quarter on quarter, overall rank is .


Akers Biosciences Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Net Income 12 Months Ending $ -15.63 $ -9.34 $ -6.51 $ -3.89 $ -6.39
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Akers Biosciences Inc ' has realized cumulative trailing twelve months net loss of $ -16 millions in the Sep 30 2020 period.
The situation is getting worse as the cumulative net loss is inflating from $ -9.34 millions in TTM ending quarter Jun 30 2020 and $ -3.63 millions for the twelve months ending in the quarter a year ago.

Akers Biosciences Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Akers Biosciences Inc ' has realized cumulative trailing twelve months net loss of $ -16 millions in the Sep 30 2020 period.
The results are getting worse as the cumulative net loss is becoming larger from $ -9.34 millions for the period from Jun 30 2020 to Sep 30 2019 and $ -3.63 millions from the TTM period ending Sep 30 2019.

Akers Biosciences Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
AKER's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for AKER's Competitors
Net Income Growth for Akers Biosciences Inc 's Suppliers
Net Income Growth for AKER's Customers

You may also want to know
AKER's Annual Growth Rates AKER's Profitability Ratios AKER's Asset Turnover Ratio AKER's Dividend Growth
AKER's Roe AKER's Valuation Ratios AKER's Financial Strength Ratios AKER's Dividend Payout Ratio
AKER's Roa AKER's Inventory Turnover Ratio AKER's Growth Rates AKER's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2020
Insulet Corporation  1,261.50 %$ 1,261.502 millions
Vertex Pharmaceuticals Inc  1,060.39 %$ 1,060.392 millions
Retractable Technologies Inc  988.56 %$ 988.562 millions
Repligen Corp  777.15 %$ 777.155 millions
Nature s Sunshine Products inc   430.64 %$ 430.644 millions
Inspyr Therapeutics Inc   400.24 %$ 400.238 millions
Phibro Animal Health Corp  389.15 %$ 389.145 millions
Amphastar Pharmaceuticals Inc   387.09 %$ 387.093 millions
Novocure Limited  381.04 %$ 381.036 millions
Antares Pharma Inc   379.00 %$ 379.003 millions
Abiomed Inc   375.96 %$ 375.962 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SNWV's Profile

Stock Price

SNWV's Financials

Business Description

Fundamentals

Charts & Quotes

SNWV's News

Suppliers

SNWV's Competitors

Customers & Markets

Economic Indicators

SNWV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071